Literature DB >> 3132439

Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo.

P Davey1, M Barza, M Stuart.   

Abstract

In the rat croton oil pouch model, treatment with ciprofloxacin, gentamicin or imipenem caused a sharp reduction in the numbers of Pseudomonas aeruginosa when applied 24 h after infection but treatment had little or no effect when delayed until 48 h after infection. Surviving bacteria from treated animals were fully susceptible on subculture in vitro. Between 24 h and 48 h after infection there was an increase in the concentration of magnesium and a decrease in the concentration of oxygen but no significant change in the pH of the pouch fluid. In-vitro, the MBC of gentamicin was increased four-fold by the addition of magnesium ions and eight-fold under anaerobic conditions whereas these variables had no significant effect upon the MBC of ciprofloxacin and imipenem. However, cells of P. aeruginosa incubated in batch culture for 4, 24 and 48 h became progressively more tolerant to killing by all three drugs. We conclude that the tolerance of P. aeruginosa in vivo was only partly explained by biochemical changes at the site of infection. The stationary growth phase was associated with progressive tolerance to killing by ciprofloxacin, gentamicin and imipenem both in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132439     DOI: 10.1093/jac/21.4.395

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

Authors:  Dominic Hill; Barbara Rose; Aniko Pajkos; Michael Robinson; Peter Bye; Scott Bell; Mark Elkins; Barbara Thompson; Colin Macleod; Shawn D Aaron; Colin Harbour
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Novel RpoS-Dependent Mechanisms Strengthen the Envelope Permeability Barrier during Stationary Phase.

Authors:  Angela M Mitchell; Wei Wang; Thomas J Silhavy
Journal:  J Bacteriol       Date:  2016-12-28       Impact factor: 3.490

3.  Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro.

Authors:  C König; H P Simmen; J Blaser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

4.  Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.

Authors:  T R Field; A White; J S Elborn; M M Tunney
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-10       Impact factor: 3.267

5.  Identification of a pKM101 region which confers a slow growth rate and interferes with susceptibility to quinolone in Escherichia coli AB1157.

Authors:  B Clerch; E Rivera; M Llagostera
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

6.  Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin.

Authors:  Marshall C Walters; Frank Roe; Amandine Bugnicourt; Michael J Franklin; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 7.  Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.

Authors:  A Dalhoff
Journal:  Infection       Date:  1994       Impact factor: 3.553

8.  Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.

Authors:  R Roosendaal; I A Bakker-Woudenberg; M van den Berghe-van Raffe; J C Vink-van den Berg; M F Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

9.  Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.

Authors:  Giorgia Borriello; Erin Werner; Frank Roe; Aana M Kim; Garth D Ehrlich; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.